Treatment of former smokers with 9-cis-retinoic acid reverse loss of retinoic acid receptor-β expression in the bronchial epithelium: Results from a randomized placebo-controlled trial

Journal of the National Cancer Institute

Volumn 95, Issue 3, 2003, Pages 206-214

  Kurie, Jonathan M ^a   Lotan, Reuben ^a   Lee, J Jack ^a   Lee, Jin Soo ^a   Morice, Rodolfo C ^a   Liu, Diane D ^a   Xu, Xiao Chun ^a   Khuri, Fadlo R ^a   Ro, Jae Y ^a   Hittelman, Walter N ^a   Walsh, Garrett L ^a   Roth, Jack A ^a   Minna, John D ^b   Hong, Waun Ki ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA TOCOPHEROL; ISOTRETINOIN; PLACEBO; RETINOIC ACID RECEPTOR BETA;

ADULT; AGED; ARTHRALGIA; ARTICLE; BRONCHOSCOPY; BRONCHUS CANCER; BRONCHUS MUCOSA; CARCINOGENESIS; CARCINOMA IN SITU; CHEILITIS; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MYALGIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RASH; SMOKING; SMOKING CESSATION; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0037420022     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.3.206     Document Type: Article

References (32)

1. Stewart AK, Bland KI, McGinnis LS Jr, Morrow M, Eyre HJ. Clinical highlights from the National Cancer Institute database. CA Cancer J Clin 2000;50:171-83.
2. Walsh GL, Pisters KM, Stevens C. Treatment of stage I lung cancer. Chest Surg Clin N Am 2001;11:17-38.
3. Burns DM. Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer 2000;89: 2506-9.
4. Kurie JM. The biologic basis for the use of retinoids in cancer prevention and treatment. Curr Opin Oncol 1999;11:497-502.
5. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-50.
6. Marchetti MN, Samplo E, Bun H, Scoma H, Lacarelle B, Durand A. In vitro metabolism of three major isomers of retinoic acid in rats. Intersex and interstrain comparison. Drug Metab Dispos 1997;25:637-46.
7. Shalinsky DR, Bischoff ED, Gregory ML, Lamph WW, Heyman RA, Hayes JS, et al. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res 1996;2:511-20.
8. McCormick DL, Rao KV, Steele VE, Lubet RA, Kelloff GJ, Bosland MC. Chemoprevention of rat prostate carcinogenesis by 9-cis retinoic acid. Cancer Res 1999;59:521-4.
9. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, et al. Prevention of breast cancer in the rat with 9-cis retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 1994;54:4614-7.
10. Bischoff ED, Gottardis MM, Moon TE, Heyman RA, Lamph WW. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Res 1998;58:479-84.
11. Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. Chemoprevention of mammary carcinoma by LGD1069 Targretin: an RXR-selective ligand. Cancer Res 1996;56:5566-70.
12. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-7.
13. Lotan R, Xu XC, Lippman SM, Ro YJ, Lee JS, Lee JJ, et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-10.
14. Xu XC, Sozzi G, Lee LS, Lee JJ, Pastorino U, Pilotti S, et al. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997;89:624-9.
15. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
16. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
17. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001;93:605-18.
18. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994;12:937-45.
19. Sawant SS, Kandarkar SV. Role of vitamins C and E as chemopreventive agents in the hamster cheek pouch treated with the oral carcinogen-DMBA. Oral Dis 2000;6:241-7.
20. Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA Jr, et al. Phase I trial of alpha-tocopherol effects on 13-cis retinoic acid toxicity. Ann Oncol 1997;8:85-9.
21. Kurie JM, Lee JS, Griffin T, Lippman SM, Drum P, Thomas MP, et al. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996;2:287-93.
22. Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, et al. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996;2:471-5.
23. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, et al. N-(4-hydroxyphenyl retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 2000;6: 2973-9.
24. Xu XC, Clifford JL, Hong WK, Lotan R. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diagn Mol Pathol 1994;3:122-31.
25. Agresti A. Categorical data analysis. New York NY: John Wiley and Sons; 1990. p. 348-52.
26. Diggle PJ, Liang KY, Zeger SL, editors. Analysis of longitudinal data. New York NY: Oxford University Press; 1994. p. 143-59.
27. Lotan R, Dawson MI, Zou CC, Jong L, Lotan D, Zou CP. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res 1995;55:232-6.
28. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, et al. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999;91:1317-21.
29. Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, et al. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst 2001;93:1081-8.
30. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315: 1501-5.
31. Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, et al. A phase I study of LGD1069 in adults with advanced cancer. Clin Cancer Res 1999;5:1658-64.
32. Dawson MI, Jong L, Hobbs PD, Cameron JF, Chao WR, Pfahl M, et al. 1. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem 1995;38:3368-83.